97917473 - GLIMMUNE THERAPEUTICS

Information

• Trademark
• 97917473

• Source

• Serial Number

  97917473

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 02, 2023
  a year ago

• Transaction Date

  December 02, 2024
  2 months ago

• Status Date

  December 02, 2024
  2 months ago

• Published for Opposition Date

  March 05, 2024
  12 months ago

• Location Date

  April 30, 2024
  10 months ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BURDECKI, ANNIE

• Attorney Docket Number

  4007-114TMUS

  Attorney Name

  Maxim A. Voltchenko

  Law Office Assigned Location Code

  L80

• Owners

  • Glenmark Pharmaceuticals Limited

Case File Statements

• GS0051: Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma

Case File Event Statements

• 5/5/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/14/2024 - a year ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/14/2024 - a year ago

  6 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/5/2024 - 12 months ago

  7 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/5/2024 - 12 months ago

  8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/30/2024 - 10 months ago

  9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/2/2024 - 2 months ago

  10 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 12/2/2024 - 2 months ago

  11 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 1/26/2024 - a year ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/31/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/23/2024 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK